Qiagen N.V.

  • WKN: A2DKCH
  • ISIN: NL0012169213
  • Land: The Netherlands

Nachricht vom 21.10.2017 | 18:10

QIAGEN N.V.: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

QIAGEN N.V.

21.10.2017 / 18:10
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The AFM (the Netherlands Authority For the Financial Markets) has informed us on October 18, 2017 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 16 oct 2017
Person obliged to notify: Goldman Sachs Group Inc., The
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Ordinary share 481.985,00 481.985,00 Real Real Indirectly - Goldman Sachs Asset Management, L.P. Physical Delivery
Ordinary share 151.651,00 151.651,00 Real Real Indirectly - Goldman Sachs Asset Management International Physical Delivery
Ordinary share 15.145,00 15.144,85 Real Real Indirectly - Goldman Sachs Asset Management Co., LTD. Physical Delivery
Ordinary share 433.133,00 433.133,00 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
Forward contract 778.160,00 778.160,00 Potential Potential Indirectly - Goldman Sachs International In Cash
Forward contract 777.516,00 777.516,00 Potential Potential Indirectly - Goldman, Sachs & Co. LLC In Cash
Contract for difference 18.284,00 18.284,00 Potential Potential Indirectly - Goldman, Sachs & Co. LLC In Cash
Ordinary share 842.736,00 842.736,00 Potential Potential Indirectly - Goldman, Sachs & Co. LLC Physical Delivery
Option 6.975.943,00 6.975.943,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC Physical Delivery
Swap 128.447,00 128.447,00 Potential Potential Indirectly - Goldman Sachs & Co. LLC In Cash
Convertible bond 421.444,00 421.444,00 Potential Potential Indirectly - Goldman Sachs International Physical Delivery
Ordinary share 13.516,00 13.516,00 Real Real Indirectly - Goldman Sachs & Co. LLC Physical Delivery
 

Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 4,78 % 0,00 % 0,00 % 0,29 % 4,49 %
Voting rights 4,78 % 0,00 % 0,00 % 0,29 % 4,49 %
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=50191



21.10.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

M1 Kliniken AG: Kursziel angehoben

Die M1 Kliniken AG hat den eingeschlagenen Wachstumskurs mit einem Umsatzanstieg von 20,3 % auch im ersten Halbjahr fortgesetzt. Analog dazu gelang es der Gesellschaft, einen überproportionalen Anstieg des EBIT um 36,5% zu erreichen und unsere Erwartungen zu übertreffen. Wir haben auf dieser Grundlage unsere Umsatz- und Ergebnisschätzungen angehoben. Bei einem Kursziel von 16,15 € ergibt sich ein hohes Kurspotenzial - damit lautet das Rating KAUFEN.

News im Fokus

ProSiebenSat.1 Media SE: Thomas Ebeling verlässt das Unternehmen Ende Februar 2018

19. November 2017, 19:10

Aktueller Webcast

ADO Properties S.A.

9M RESULTS 2017

15. November 2017

Aktuelle Research-Studie

MOLOGEN AG

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

20. November 2017